Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a new regulator of the innate immune response – the immediate, natural immune response to foreign invaders. The study, published recently in Nature Microbiology , suggests that therapeutics that modulate the regulator – an immune checkpoint – may represent the next generation of antiviral drugs, vaccine adjuvants, cancer immunotherapies, and treatments for autoimmune disease.